The in vitro induced CDH1 silencing strongly correlates with the promoter methylation of other genes, such as ESR1 (encoding for the estrogen receptor alpha), silenced in a subset of invasive breast cancer (TNBC, triple-negative breast cancer). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.